Triumvira Immunologics Appoints Life Sciences Industry Leader Robert Williamson as President and Chief Business Officer
Triumvira Immunologics, Inc. (“Triumvira”), a clinical-stage company developing novel, targeted autologous and allogeneic T cell therapeutics that co-opt the natural biology of T cells to treat patients with cancer, today announced the appointment of Robert Williamson as President and Chief Business Officer ...
Source: pharmiweb.com